STEPHEN ROCAMBOLI - 28 Apr 2022 Form 3 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Benjamin Looker
Issuer symbol
ESPR
Transactions as of
28 Apr 2022
Net transactions value
$0
Form type
3
Filing time
28 Apr 2022, 16:37:46 UTC
Next filing
17 May 2022

No securities are beneficially owned.